Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.

Details

Language :

English

ISSN :

1021335X

Volume :

35

Issue :

6

Database :

Complementary Index

Journal :

Oncology Reports

Publication Type :

Academic Journal

Accession number :

115902449

Full Text :

https://doi.org/10.3892/or.2016.4764